High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer.
about
High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate CancerA review of the past, present, and future directions of neoplasiaNeoplasia: Where We Have Been and Where We Are GoingIntegrated analysis of gene expression and tumor nuclear image profiles associated with chemotherapy response in serous ovarian carcinomaInduction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancerGenes and proteins differentially expressed during in vitro malignant transformation of bovine pancreatic duct cells.High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors.Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas.S1P metabolism in cancer and other pathological conditions.Potential implications of GRP58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy.A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive diseaseDifferential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.Cancer gene discovery in mouse and man.The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells.Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancerA distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.Chromosome 6p amplification and cancer progression.RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant markerHigh mobility group protein B1 is an activator of apoptotic response to antimetabolite drugs.Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer.Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer.Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomasChromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage.The chemiluminescence based Ziplex automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip expression profilesLyase to live by: sphingosine phosphate lyase as a therapeutic target.Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomasLarge-scale genomic analysis of ovarian carcinomasSphingosine 1-phosphate signalling in cancer.Nanoparticle probes and mid-infrared chemical imaging for DNA microarray detection.Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1.Neoplasia: An Anniversary of Progress.Kinesin family member 14 in human oral cancer: A potential biomarker for tumoral growth.Comparison of Clinical Subgroup aCGH Profiles through Pseudolikelihood Ratio Tests.SET complex in serous epithelial ovarian cancer
P2860
Q26774902-210E906D-8F1B-4EA7-8971-80FE0663B672Q28389391-8424A39D-DA62-497C-853B-61CD78A6CD9AQ28395095-5C9BA98E-D386-48E5-A2AC-F9485C406A1AQ28483533-B7BA8791-1FE5-44F7-96DA-61BD689C4990Q28534358-BC3C263B-54F5-4EF5-85E6-0D2A7F81F5D9Q33278299-6C21E387-87AE-4A6A-8FD3-3B522E66ABEFQ33440056-D1027612-8453-4EFA-B825-9C82F36467BCQ33511042-69FD4CB9-5D53-45B1-92F9-CC1021A5783EQ33886533-1F008DF1-D6B5-42F2-AA49-C8B3918C6C10Q34042813-8A18DFED-F606-4FDC-B974-B106C520E1A9Q34502522-05E2E4DE-8735-4BE7-A223-6C033E71A780Q34518736-8AE2552D-75F9-47D1-A0C0-8EE1CB44761CQ34962407-B79ADC4C-75BA-4F38-B714-1AA52D668645Q34998666-7E5C2B3D-8A94-477D-B9EF-E5A5C269A87BQ35044404-28B9C9EA-E188-4E40-94D0-880F6E8D8F03Q35274995-E3F8E337-40E3-4F47-A86D-BDD074D76BECQ35770642-608BBF14-6D2D-4458-9B3F-DFD1E65FCC58Q35786661-AE31D515-ECF3-45D2-B7D1-CD569F895345Q36396288-0C1D4436-F2AF-45B7-A95E-88B3F41E2E10Q36897779-1E6D374C-FAAE-45CF-8608-32398D7B2935Q36944199-DF7BCA73-B66F-4282-9521-EBB807E2EA2CQ37161861-30850E41-4B95-4BD5-89A3-1AEC26536679Q37199282-92355340-3BE7-4BB1-B3C2-60FD202D47A9Q37299167-3D5FC3CA-EDC1-42E9-AFF3-F2F9571BB5EEQ37414484-A311110F-A4AA-47AE-B4FB-E74D188BFA48Q37435376-857D3EE5-80D4-460C-89B4-B2F2EE28F01DQ37453861-99DED50F-A446-4527-A0FF-FF3EFD62303DQ37977171-4BCC532D-5E3F-47EF-A88C-35E305F5E827Q38339418-625389D5-4898-4192-8BE6-3C8FB76A9B06Q45087026-9ADCAA7C-8194-4B9C-9932-2C8EB9167363Q45863941-22B2C2E9-7680-4F41-B47D-E12D5E182BF9Q46932476-FC9B8764-8DC8-42D0-BF70-14259C5787EBQ47094090-5EF02830-156D-4024-8753-4D01321A19D5Q55191112-5E258723-D434-4C21-869A-46AFC4440F63Q58325223-5F773ACD-891F-4CEB-951F-53FD967BB7E7
P2860
High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
High-resolution mapping of gen ...... ous epithelial ovarian cancer.
@ast
High-resolution mapping of gen ...... ous epithelial ovarian cancer.
@en
High-resolution mapping of gen ...... ous epithelial ovarian cancer.
@nl
type
label
High-resolution mapping of gen ...... ous epithelial ovarian cancer.
@ast
High-resolution mapping of gen ...... ous epithelial ovarian cancer.
@en
High-resolution mapping of gen ...... ous epithelial ovarian cancer.
@nl
prefLabel
High-resolution mapping of gen ...... ous epithelial ovarian cancer.
@ast
High-resolution mapping of gen ...... ous epithelial ovarian cancer.
@en
High-resolution mapping of gen ...... ous epithelial ovarian cancer.
@nl
P2093
P2860
P356
P1433
P1476
High-resolution mapping of gen ...... ous epithelial ovarian cancer.
@en
P2093
Barry Rosen
Ben Beheshti
Chung-Hae Lee
Heather Begley
Joan Murphy
Marcus Bernardini
Mona Prasad
Monique Albert
Pascale F Macgregor
P2860
P304
P356
10.1593/NEO.04760
P577
2005-06-01T00:00:00Z